RECOMBINANT HUMAN FACTOR-XA(ASN322ALA419) IS A POTENT ANTITHROMBOTIC AGENT IN A RABBIT MODEL OF VENOUS THROMBOSIS

被引：0
|
作者：
HOLLENBACH, S [1 ]
NEEDHAM, K [1 ]
FREY, L [1 ]
LIN, PH [1 ]
HANCOCK, TE [1 ]
SINHA, U [1 ]
WOLF, DL [1 ]
机构：
[1] COR THERAPEUT INC,S SAN FRANCISCO,CA
来源：
CIRCULATION | 1992年 / 86卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：410 / 410
页数：1
相关论文
共 34 条
  • [11] ABBREVIATED THERAPY WITH THE SELECTIVE FACTOR-XA INHIBITOR, RECOMBINANT TICK ANTICOAGULANT PEPTIDE (RTAP), PROVIDES SUSTAINED ANTITHROMBOTIC EFFICACY IN A BABOON MODEL OF VASCULAR GRAFT THROMBOSIS
    HARVEY, CM
    NUTT, EM
    SIEGL, PKS
    SCHAFFER, LW
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 569 - 569
  • [12] A NOVEL ANTITHROMBOTIC - RECOMBINANT HUMAN THROMBOMODULIN ANALOG PREVENTS VENOUS THROMBOSIS IN A RAT MODEL
    SOLIS, MM
    COOK, C
    LIGHT, D
    MORSER, J
    FINK, L
    EIDT, JF
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 948 - 948
  • [13] Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis
    Rogers, KL
    Chi, L
    Rapundalo, ST
    Kramer, JB
    Gallagher, KP
    BASIC RESEARCH IN CARDIOLOGY, 1999, 94 (01) : 15 - 22
  • [14] Effects of a factor Xa inhibitor, DX-9065a, in a novel rabbit model of venous thrombosis
    K.L. Rogers
    L. Chi
    S.T. Rapundalo
    J.B. Kramer
    K.P. Gallagher
    Basic Research in Cardiology, 1999, 94 : 15 - 22
  • [15] Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis
    Golino, P
    Ragni, M
    Cirillo, P
    D'Andrea, D
    Scognamiglio, A
    Ravera, A
    Buono, C
    Ezban, M
    Corcione, N
    Vigorito, F
    Condorelli, M
    Chiariello, M
    CIRCULATION RESEARCH, 1998, 82 (01) : 39 - 46
  • [16] Antithrombotic effects of human recombinant active-site blocked factor VII in a rabbit model of recurrent arterial thrombosis
    Ragni, M
    Cirillo, P
    Ezban, M
    Scognamiglio, A
    Ravera, A
    Esposito, N
    Chiariello, M
    Golino, P
    CIRCULATION, 1996, 94 (08) : 4065 - 4065
  • [17] ANTITHROMBOTIC PROPERTIES OF A TRUNCATED RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR IN AN EXPERIMENTAL VENOUS THROMBOSIS MODEL
    HOLST, J
    LINDBLAD, B
    BERGQVIST, D
    NORDFANG, O
    OSTERGAARD, PB
    PETERSEN, JL
    NIELSEN, G
    HEDNER, U
    HAEMOSTASIS, 1993, 23 : 112 - 117
  • [18] Antithrombotic and Anticoagulant Profiles of TAK-442, a Novel Factor Xa Inhibitor, in a Rabbit Model of Venous Thrombosis (vol 56, pg 156, 2010)
    Kawamura, M.
    Konishi, N.
    Hiroe, K.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2010, 56 (04) : 439 - 439
  • [19] COMPARISON OF THE INVIVO ANTICOAGULANT PROPERTIES OF STANDARD HEPARIN AND THE HIGHLY SELECTIVE FACTOR-XA INHIBITORS ANTISTASIN AND TICK ANTICOAGULANT PEPTIDE (TAP) IN A RABBIT MODEL OF VENOUS THROMBOSIS
    VLASUK, GP
    RAMJIT, D
    FUJITA, T
    DUNWIDDIE, CT
    NUTT, EM
    SMITH, DE
    SHEBUSKI, RJ
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (03) : 257 - 262
  • [20] Nonpeptide factor Xa inhibitors II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis
    Wong, PC
    Crain, EJ
    Knabb, RM
    Meade, RP
    Quan, ML
    Watson, CA
    Wexler, RR
    Wright, MR
    Slee, AM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (01): : 212 - 218
1234